ANTICANCER DRUG CONTAINING COMPOUND KR-15012

摘要

PURPOSE: An anticancer drug containing a compound KR-15012 is provided, which has anticancer activity better than or equal to doxorubicin and excellent anticancer effect against cancer cell strains exhibiting resistance to conventional anticancer drugs such as doxorubicin and cisplatin. CONSTITUTION: An anticancer drug containing a compound KR-15012 represented by the formula 1 or salts thereof. The anticancer drug exhibits excellent anticancer effect against a cancer cell selected from the group consisting of A-549, SK-OV-3, SK-MEL-2, XF498 and HCT15, DCT15/ADM, A2780 and CP70.